Cargando…
Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches
Inflammatory bowel disease (IBD) is a complex heterogeneous disorder defined by recurring chronic inflammation of the gastrointestinal tract, attributed to a combination of factors including genetic susceptibility, altered immune response, a shift in microbial composition/microbial insults (infectio...
Autores principales: | O’Reilly, Catherine, Mills, Susan, Rea, Mary C., Lavelle, Aonghus, Ghosh, Subrata, Hill, Colin, Ross, R. Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7615213/ https://www.ncbi.nlm.nih.gov/pubmed/37849974 http://dx.doi.org/10.20517/mrr.2023.41 |
Ejemplares similares
-
Modulation of the gut microbiome with nisin
por: O’Reilly, Catherine, et al.
Publicado: (2023) -
Perturbation of the Human Microbiome as a Contributor to Inflammatory Bowel Disease
por: Missaghi, Bayan, et al.
Publicado: (2014) -
Interplays between drugs and the gut microbiome
por: Wan, Yating, et al.
Publicado: (2022) -
The gut microbiome: Relationships with disease and opportunities for therapy
por: Durack, Juliana, et al.
Publicado: (2019) -
Dynamics of the human gut microbiome in Inflammatory Bowel Disease
por: Halfvarson, Jonas, et al.
Publicado: (2017)